SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corixa [CRXA] - cancer vaccines

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Micawber who wrote (48)2/15/2001 1:12:30 PM
From: Micawber   of 222
 
Thursday February 15, 12:54 pm Eastern Time

Corixa tumbles as psoriasis drug fails Phase II trial

NEW YORK, Feb 15 (Reuters) - Shares of Corixa Corp (NasdaqNM:CRXA - news) tumbled to near a 52-week-low on Thursday after the firm said its experimental psoriasis treatment PVAC failed to achieve statistically significant effectiveness in a Phase II trial.

biz.yahoo.com

The firm said nothing of the sort. The firm said in their PR that it was a rousing success. Whatever.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext